Detailed Mechanism Funding and Narrative

Years of mechanism: 2017 2018 2019

Details for Mechanism ID: 18494
Country/Region: Kenya
Year: 2018
Main Partner: Program for Appropriate Technology in Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $19,711,347 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $0
Care: Orphans and Vulnerable Children (HKID) $0
Care: TB/HIV (HVTB) $0
Care: Pediatric Care and Support (PDCS) $0
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Health Systems Strengthening (OHSS) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $1,634,200
Biomedical Prevention: Blood Safety (HMBL) $0
Biomedical Prevention: Injection Safety (HMIN) $0
Sexual Prevention: Abstinence/Be Faithful (HVAB) $967,373
Testing: HIV Testing and Counseling (HVCT) $4,165,994
Sexual Prevention: Other Sexual Prevention (HVOP) $6,499,492
Prevention: Injecting and Non-Injecting Drug Use (IDUP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $646,845
Treatment: ARV Drugs (HTXD) $0
Treatment: Adult Treatment (HTXS) $5,451,494
Treatment: Pediatric Treatment (PDTX) $345,949
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV <10, Female, Physical and/or Emotional Violence 2019 413
GEND_GBV <10, Female, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV <10, Male, Physical and/or Emotional Violence 2019 413
GEND_GBV <10, Male, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV 10-14, Female, Physical and/or Emotional Violence 2019 1,238
GEND_GBV 10-14, Female, Sexual Violence (Post-Rape Care) 2019 1,238
GEND_GBV 10-14, Male, Physical and/or Emotional Violence 2019 413
GEND_GBV 10-14, Male, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV 15-19, Female, Physical and/or Emotional Violence 2019 4,127
GEND_GBV 15-19, Female, Sexual Violence (Post-Rape Care) 2019 4,127
GEND_GBV 15-19, Male, Physical and/or Emotional Violence 2019 413
GEND_GBV 15-19, Male, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV 20-24, Female, Physical and/or Emotional Violence 2019 5,778
GEND_GBV 20-24, Female, Sexual Violence (Post-Rape Care) 2019 5,778
GEND_GBV 20-24, Male, Physical and/or Emotional Violence 2019 413
GEND_GBV 20-24, Male, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV 25-29, Female, Physical and/or Emotional Violence 2019 1,238
GEND_GBV 25-29, Female, Sexual Violence (Post-Rape Care) 2019 1,238
GEND_GBV 25-29, Male, Physical and/or Emotional Violence 2019 413
GEND_GBV 25-29, Male, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV 30-34, Female, Physical and/or Emotional Violence 2019 1,238
GEND_GBV 30-34, Female, Sexual Violence (Post-Rape Care) 2019 1,238
GEND_GBV 30-34, Male, Physical and/or Emotional Violence 2019 413
GEND_GBV 30-34, Male, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV 35-39, Female, Physical and/or Emotional Violence 2019 1,238
GEND_GBV 35-39, Female, Sexual Violence (Post-Rape Care) 2019 1,238
GEND_GBV 35-39, Male, Physical and/or Emotional Violence 2019 413
GEND_GBV 35-39, Male, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV 40-49, Female, Physical and/or Emotional Violence 2019 1,238
GEND_GBV 40-49, Female, Sexual Violence (Post-Rape Care) 2019 1,238
GEND_GBV 40-49, Male, Physical and/or Emotional Violence 2019 413
GEND_GBV 40-49, Male, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV 50+, Female, Physical and/or Emotional Violence 2019 413
GEND_GBV 50+, Female, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV 50+, Male, Physical and/or Emotional Violence 2019 413
GEND_GBV 50+, Male, Sexual Violence (Post-Rape Care) 2019 413
GEND_GBV By PEP service provision (related to sexual violence services provided) 2019 12,640
GEND_GBV By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2019 20,630
GEND_GBV By type of service: Sexual Violence (Post-Rape Care) 2019 20,630
GEND_GBV Number of people receiving post-GBV care 2019 41,267
HTS_SELF 2019 2,506
HTS_SELF 10-14, Female, Directly-Assisted 2019 5
HTS_SELF 15-19, Female, Directly-Assisted 2019 135
HTS_SELF 15-19, Female, Unassisted 2019 135
HTS_SELF 15-19, Male, Directly-Assisted 2019 44
HTS_SELF 15-19, Male, Unassisted 2019 44
HTS_SELF 20-24, Female, Directly-Assisted 2019 135
HTS_SELF 20-24, Female, Unassisted 2019 135
HTS_SELF 20-24, Male, Directly-Assisted 2019 44
HTS_SELF 20-24, Male, Unassisted 2019 44
HTS_SELF 25-29, Female, Directly-Assisted 2019 135
HTS_SELF 25-29, Female, Unassisted 2019 135
HTS_SELF 25-29, Male, Directly-Assisted 2019 44
HTS_SELF 25-29, Male, Unassisted 2019 44
HTS_SELF 30-34, Female, Directly-Assisted 2019 135
HTS_SELF 30-34, Female, Unassisted 2019 135
HTS_SELF 30-34, Male, Directly-Assisted 2019 44
HTS_SELF 30-34, Male, Unassisted 2019 44
HTS_SELF 35-39, Female, Directly-Assisted 2019 135
HTS_SELF 35-39, Female, Unassisted 2019 135
HTS_SELF 35-39, Male, Directly-Assisted 2019 44
HTS_SELF 35-39, Male, Unassisted 2019 44
HTS_SELF 40-49, Female, Directly-Assisted 2019 135
HTS_SELF 40-49, Female, Unassisted 2019 135
HTS_SELF 40-49, Male, Directly-Assisted 2019 44
HTS_SELF 40-49, Male, Unassisted 2019 44
HTS_SELF 50+, Female, Directly-Assisted 2019 135
HTS_SELF 50+, Female, Unassisted 2019 135
HTS_SELF 50+, Male, Directly-Assisted 2019 44
HTS_SELF 50+, Male, Unassisted 2019 44
HTS_SELF Directly-Assisted 2019 1,256
HTS_SELF FSW, Directly-Assisted 2019 1,676
HTS_SELF MSM, Directly-Assisted 2019 375
HTS_SELF PWID, Directly-Assisted 2019 150
HTS_SELF Unassisted 2019 1,250
HTS_SELF Unassisted - Other 2019 125
HTS_SELF Unassisted - Self 2019 625
HTS_SELF Unassisted - Sex Partner 2019 500
HTS_TST <5, Unknown Sex, Negative 2019 2,226
HTS_TST 15-19, Female, Negative 2019 503
HTS_TST 15-19, Male, Negative 2019 284
HTS_TST 20-24, Female, Negative 2019 1,745
HTS_TST 20-24, Male, Negative 2019 905
HTS_TST 25-29, Female, Negative 2019 1,988
HTS_TST 25-29, Female, Negative 2019 168
HTS_TST 25-29, Female, Negative 2019 421
HTS_TST 25-29, Female, Negative 2019 2
HTS_TST 25-29, Female, Negative 2019 31
HTS_TST 25-29, Female, Negative 2019 2,708
HTS_TST 25-29, Female, Negative 2019 3,736
HTS_TST 25-29, Female, Negative 2019 87
HTS_TST 25-29, Female, Negative 2019 61
HTS_TST 25-29, Male, Negative 2019 10,630
HTS_TST 25-29, Male, Negative 2019 3,985
HTS_TST 25-29, Male, Negative 2019 964
HTS_TST 25-29, Male, Negative 2019 1,090
HTS_TST 25-29, Male, Negative 2019 1,752
HTS_TST 25-29, Male, Negative 2019 90
HTS_TST 25-29, Male, Negative 2019 20,774
HTS_TST 25-29, Male, Negative 2019 430
HTS_TST 25-29, Male, Negative 2019 85
HTS_TST 30-34, Female, Negative 2019 2,274
HTS_TST 30-34, Female, Negative 2019 193
HTS_TST 30-34, Female, Negative 2019 480
HTS_TST 30-34, Female, Negative 2019 3
HTS_TST 30-34, Female, Negative 2019 36
HTS_TST 30-34, Female, Negative 2019 3,415
HTS_TST 30-34, Female, Negative 2019 3,736
HTS_TST 30-34, Female, Negative 2019 100
HTS_TST 30-34, Female, Negative 2019 54
HTS_TST 30-34, Male, Negative 2019 12,760
HTS_TST 30-34, Male, Negative 2019 1,151
HTS_TST 30-34, Male, Negative 2019 1,307
HTS_TST 30-34, Male, Negative 2019 2,103
HTS_TST 30-34, Male, Negative 2019 109
HTS_TST 30-34, Male, Negative 2019 24,487
HTS_TST 30-34, Male, Negative 2019 518
HTS_TST 30-34, Male, Negative 2019 98
HTS_TST 35-39, Female, Negative 2019 567
HTS_TST 35-39, Female, Negative 2019 48
HTS_TST 35-39, Female, Negative 2019 120
HTS_TST 35-39, Female, Negative 2019 1
HTS_TST 35-39, Female, Negative 2019 9
HTS_TST 35-39, Female, Negative 2019 1,408
HTS_TST 35-39, Female, Negative 2019 3,736
HTS_TST 35-39, Female, Negative 2019 25
HTS_TST 35-39, Female, Negative 2019 70
HTS_TST 35-39, Male, Negative 2019 12,760
HTS_TST 35-39, Male, Negative 2019 1,151
HTS_TST 35-39, Male, Negative 2019 1,307
HTS_TST 35-39, Male, Negative 2019 2,103
HTS_TST 35-39, Male, Negative 2019 109
HTS_TST 35-39, Male, Negative 2019 22,258
HTS_TST 35-39, Male, Negative 2019 518
HTS_TST 35-39, Male, Negative 2019 138
HTS_TST 40-49, Female, Negative 2019 567
HTS_TST 40-49, Female, Negative 2019 48
HTS_TST 40-49, Female, Negative 2019 120
HTS_TST 40-49, Female, Negative 2019 1
HTS_TST 40-49, Female, Negative 2019 9
HTS_TST 40-49, Female, Negative 2019 1,408
HTS_TST 40-49, Female, Negative 2019 3,736
HTS_TST 40-49, Female, Negative 2019 25
HTS_TST 40-49, Female, Negative 2019 54
HTS_TST 40-49, Male, Negative 2019 126
HTS_TST 40-49, Male, Negative 2019 4,253
HTS_TST 40-49, Male, Negative 2019 384
HTS_TST 40-49, Male, Negative 2019 434
HTS_TST 40-49, Male, Negative 2019 701
HTS_TST 40-49, Male, Negative 2019 36
HTS_TST 40-49, Male, Negative 2019 7,416
HTS_TST 40-49, Male, Negative 2019 167
HTS_TST 50+, Female, Negative 2019 13
HTS_TST 50+, Male, Negative 2019 74
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 459,063
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 41
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 61
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 142
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 193
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 4
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 18
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 466
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 843
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 1,606
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 2,698
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 350
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 134
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 6,298
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 13,419
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 13
HTS_TST Service Delivery Point (Facility) Index: <1, Negative 2019 140
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 941
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 189
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 119
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 654
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 648
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 2,260
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 2,160
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 24
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 193
HTS_TST Service Delivery Point (Facility) Inpatient: <1, Negative 2019 15
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 214
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 26
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 13
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 881
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 913
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 3,051
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 2,927
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 60
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 214
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 4,219
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 840
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 548
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 11,023
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 19,120
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 55,437
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 44,961
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 704
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 3,716
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 3,178
HTS_TST Service Delivery Point (Facility) TB: 1-9, Negative 2019 29
HTS_TST Service Delivery Point (Facility) TB: 10-14, Female, Negative 2019 51
HTS_TST Service Delivery Point (Facility) TB: 10-14, Male, Negative 2019 47
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 63
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 86
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 63
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 91
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 63
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 101
HTS_TST Service Delivery Point (Facility) VCT: <1, Negative 2019 13
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 163
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 21
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 46
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 9,374
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 7,325
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 32,362
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 23,442
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 283
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 2,133
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 1,825
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 5,976
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 5,954
HTS_TST Service Delivery Point (Facility)Other PITC: <1, Negative 2019 606
HTS_TST_POS <5, Unknown Sex, Positive 2019 4
HTS_TST_POS 15-19, Male, Positive 2019 1
HTS_TST_POS 20-24, Female, Positive 2019 1
HTS_TST_POS 20-24, Male, Positive 2019 2
HTS_TST_POS 25-29, Female, Positive 2019 23
HTS_TST_POS 25-29, Female, Positive 2019 34
HTS_TST_POS 25-29, Female, Positive 2019 7
HTS_TST_POS 25-29, Female, Positive 2019 2
HTS_TST_POS 25-29, Female, Positive 2019 55
HTS_TST_POS 25-29, Female, Positive 2019 614
HTS_TST_POS 25-29, Female, Positive 2019 4
HTS_TST_POS 25-29, Male, Positive 2019 134
HTS_TST_POS 25-29, Male, Positive 2019 194
HTS_TST_POS 25-29, Male, Positive 2019 16
HTS_TST_POS 25-29, Male, Positive 2019 2
HTS_TST_POS 25-29, Male, Positive 2019 415
HTS_TST_POS 25-29, Male, Positive 2019 1
HTS_TST_POS 25-29, Male, Positive 2019 8
HTS_TST_POS 30-34, Female, Positive 2019 26
HTS_TST_POS 30-34, Female, Positive 2019 40
HTS_TST_POS 30-34, Female, Positive 2019 8
HTS_TST_POS 30-34, Female, Positive 2019 2
HTS_TST_POS 30-34, Female, Positive 2019 70
HTS_TST_POS 30-34, Female, Positive 2019 33
HTS_TST_POS 30-34, Female, Positive 2019 1
HTS_TST_POS 30-34, Female, Positive 2019 4
HTS_TST_POS 30-34, Male, Positive 2019 169
HTS_TST_POS 30-34, Male, Positive 2019 233
HTS_TST_POS 30-34, Male, Positive 2019 18
HTS_TST_POS 30-34, Male, Positive 2019 2
HTS_TST_POS 30-34, Male, Positive 2019 485
HTS_TST_POS 30-34, Male, Positive 2019 1
HTS_TST_POS 30-34, Male, Positive 2019 8
HTS_TST_POS 35-39, Female, Positive 2019 7
HTS_TST_POS 35-39, Female, Positive 2019 9
HTS_TST_POS 35-39, Female, Positive 2019 2
HTS_TST_POS 35-39, Female, Positive 2019 29
HTS_TST_POS 35-39, Female, Positive 2019 31
HTS_TST_POS 35-39, Female, Positive 2019 5
HTS_TST_POS 35-39, Male, Positive 2019 169
HTS_TST_POS 35-39, Male, Positive 2019 233
HTS_TST_POS 35-39, Male, Positive 2019 18
HTS_TST_POS 35-39, Male, Positive 2019 2
HTS_TST_POS 35-39, Male, Positive 2019 440
HTS_TST_POS 35-39, Male, Positive 2019 1
HTS_TST_POS 35-39, Male, Positive 2019 10
HTS_TST_POS 40-49, Female, Positive 2019 4
HTS_TST_POS 40-49, Female, Positive 2019 7
HTS_TST_POS 40-49, Female, Positive 2019 9
HTS_TST_POS 40-49, Female, Positive 2019 2
HTS_TST_POS 40-49, Female, Positive 2019 29
HTS_TST_POS 40-49, Female, Positive 2019 16
HTS_TST_POS 40-49, Male, Positive 2019 9
HTS_TST_POS 40-49, Male, Positive 2019 50
HTS_TST_POS 40-49, Male, Positive 2019 65
HTS_TST_POS 40-49, Male, Positive 2019 4
HTS_TST_POS 40-49, Male, Positive 2019 1
HTS_TST_POS 40-49, Male, Positive 2019 135
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 2
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 2
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 106
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 445
HTS_TST_POS Service Delivery Point (Facility) Index: <1, Positive 2019 13
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 143
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 138
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 505
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 437
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 34
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 26
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 107
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 72
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 1
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: <1, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 65
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 7
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 218
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 387
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 1,127
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 902
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 15
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 57
HTS_TST_POS Service Delivery Point (Facility) TB: 1-9, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Female, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 10-14, Male, Positive 2019 4
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 11
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 9
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 126
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 105
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 450
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 326
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 3
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2019 5
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 11
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 10-14 2019 519
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 15-17 2019 2,632
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Female 18-24 2019 5,124
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 10-14 2019 452
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 15-17 2019 281
OVC_SERV Required only for DREAMS countries - By service, age and sex: Economic Strengthening Male 18-24 2019 192
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 10-14 2019 6,071
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 15-17 2019 14,629
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Female 18-24 2019 11,979
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 10-14 2019 683
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 15-17 2019 454
OVC_SERV Required only for DREAMS countries - By service, age and sex: Education Support Male 18-24 2019 273
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 10-14 2019 15,591
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 15-17 2019 34,844
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Female 18-24 2019 24,955
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 10-14 2019 843
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 15-17 2019 547
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 18-24 2019 342
OVC_SERV Required only for DREAMS countries - By service, age and sex: Other Services Male 25+ 2019 1
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 10-14 2019 7,415
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 15-17 2019 1,801
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 18-24 2019 478
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Female 25+ 2019 88
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 10-14 2019 1,360
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 15-17 2019 1,324
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 18-24 2019 511
OVC_SERV Required only for DREAMS countries - By service, age and sex: Parenting/Caregiver Programs Male 25+ 2019 50
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 10-14 2019 864
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 15-17 2019 1,995
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Female 18-24 2019 2,090
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 10-14 2019 937
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 15-17 2019 357
OVC_SERV Required only for DREAMS countries - By service, age and sex: Social Protection Male 18-24 2019 220
PMTCT_ART Already on ART at beginning of current pregnancy 2019 2,494
PMTCT_ART New on ART 2019 1,187
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 3,681
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 38,864
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 314
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 314
PMTCT_EID Sum of Infant Age disaggregates 2019 314
PMTCT_STAT 25-29, Female 2019 4,344
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 416
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 3,797
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 135
PMTCT_STAT 30-34, Female 2019 4,344
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 416
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 3,797
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 135
PMTCT_STAT 35-39, Female 2019 4,344
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 416
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 3,797
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 135
PMTCT_STAT 40-49, Female 2019 4,344
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 416
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 3,797
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 135
PMTCT_STAT By Age (Numerator): 10-14 2019 151
PMTCT_STAT By Age (Numerator): 15-19 2019 6,843
PMTCT_STAT By Age (Numerator): 20-24 2019 14,849
PMTCT_STAT By Age (Numerator): 50+ 2019 29
PMTCT_STAT By Number of known positives: 10-14 2019 4
PMTCT_STAT By Number of known positives: 15-19 2019 179
PMTCT_STAT By Number of known positives: 20-24 2019 699
PMTCT_STAT By Number of known positives: 50+ 2019 1
PMTCT_STAT By Number of new negative: 10-14 2019 144
PMTCT_STAT By Number of new negative: 15-19 2019 6,433
PMTCT_STAT By Number of new negative: 20-24 2019 13,655
PMTCT_STAT By Number of new negative: 50+ 2019 26
PMTCT_STAT By Number of new positives: 10-14 2019 5
PMTCT_STAT By Number of new positives: 15-19 2019 232
PMTCT_STAT By Number of new positives: 20-24 2019 473
PMTCT_STAT By Number of new positives: 50+ 2019 1
PMTCT_STAT Number of new ANC and L&D clients 2019 40,541
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 38,864
PMTCT_STAT_den 25-29, Female 2019 4,606
PMTCT_STAT_den 30-34, Female 2019 4,606
PMTCT_STAT_den 35-39, Female 2019 4,606
PMTCT_STAT_den 40-49, Female 2019 4,606
PMTCT_STAT_den By Age (Denominator): <15-19 2019 7,030
PMTCT_STAT_den By Age (Denominator): 10-14 2019 169
PMTCT_STAT_den By Age (Denominator): 20-24 2019 14,880
PMTCT_STAT_den By Age (Denominator): 50+ 2019 38
PP_PREV 25-29, Female 2019 947
PP_PREV 25-29, Male 2019 994
PP_PREV 30-34, Female 2019 947
PP_PREV 30-34, Male 2019 994
PP_PREV 35-39, Female 2019 947
PP_PREV 35-39, Male 2019 994
PP_PREV 40-49, Female 2019 947
PP_PREV 40-49, Male 2019 994
PP_PREV Age/sex: 10-14 Female 2019 3,542
PP_PREV Age/sex: 10-14 Male 2019 365
PP_PREV Age/sex: 15-19 Female 2019 7,220
PP_PREV Age/sex: 15-19 Male 2019 1,261
PP_PREV Age/sex: 20-24 Female 2019 5,929
PP_PREV Age/sex: 20-24 Male 2019 1,653
PP_PREV Age/sex: 50+ Female 2019 440
PP_PREV Age/sex: 50+ Male 2019 444
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 28,659
PP_PREV Sum of Age/Sex disaggregates 2019 20,854
PrEP_NEW 25-29, Female 2019 247
PrEP_NEW 25-29, Male 2019 106
PrEP_NEW 30-34, Female 2019 176
PrEP_NEW 30-34, Male 2019 140
PrEP_NEW 35-39, Female 2019 176
PrEP_NEW 35-39, Male 2019 140
PrEP_NEW 40-49, Female 2019 176
PrEP_NEW 40-49, Male 2019 106
PrEP_NEW Female 15-19 2019 424
PrEP_NEW Female 20-24 2019 1,448
PrEP_NEW Female 50+ 2019 71
PrEP_NEW FSW 2019 494
PrEP_NEW Male 15-19 2019 36
PrEP_NEW Male 20-24 2019 211
PrEP_NEW Male 50+ 2019 71
PrEP_NEW MSM 2019 247
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 3,531
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 389
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 250
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 642
TB_PREV By Age/Sex (Numerator): <15, Female 2019 234
TB_PREV By Age/Sex (Numerator): <15, Male 2019 235
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 3,682
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 1,578
TB_PREV IPT, Life-long ART, New, Positive 2019 409
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 5,746
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 6,969
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 290
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 294
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 4,461
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 1,915
TB_PREV_den IPT, Life-long ART, New, Positive 2019 6,969
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 77
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 853
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 50
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 616
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 1,618
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 1,624
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 81
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 833
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 55
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 625
TX_CURR 25-29, Female, Positive 2019 7,678
TX_CURR 25-29, Male, Positive 2019 2,823
TX_CURR 30-34, Female, Positive 2019 5,824
TX_CURR 30-34, Male, Positive 2019 4,422
TX_CURR 35-39, Female, Positive 2019 5,824
TX_CURR 35-39, Male, Positive 2019 4,422
TX_CURR 40-49, Female, Positive 2019 3,971
TX_CURR 40-49, Male, Positive 2019 4,422
TX_CURR Age/Sex: <1 2019 58
TX_CURR Age/Sex: <1-9 2019 2,923
TX_CURR Age/Sex: 10-14 Female 2019 895
TX_CURR Age/Sex: 10-14 Male 2019 740
TX_CURR Age/Sex: 15-19 Female 2019 1,999
TX_CURR Age/Sex: 15-19 Male 2019 962
TX_CURR Age/Sex: 20-24 Female 2019 5,578
TX_CURR Age/Sex: 20-24 Male 2019 1,273
TX_CURR Age/Sex: 50+ Female 2019 3,157
TX_CURR Age/Sex: 50+ Male 2019 1,578
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 58,482
TX_CURR Sum of age/sex disaggregates 2019 2,961
TX_NEW 25-29, Female, Positive 2019 160
TX_NEW 25-29, Male, Positive 2019 824
TX_NEW 30-34, Female, Positive 2019 222
TX_NEW 30-34, Male, Positive 2019 976
TX_NEW 35-39, Female, Positive 2019 40
TX_NEW 35-39, Male, Positive 2019 954
TX_NEW 40-49, Female, Positive 2019 29
TX_NEW 40-49, Male, Positive 2019 305
TX_NEW Breastfeeding status 2019 401
TX_NEW By Age/Sex: <1 2019 168
TX_NEW By Age/Sex: 1-9 2019 107
TX_NEW By Age/Sex: 10-14 Female 2019 18
TX_NEW By Age/Sex: 10-14 Male 2019 12
TX_NEW By Age/Sex: 15-19 Female 2019 719
TX_NEW By Age/Sex: 15-19 Male 2019 547
TX_NEW By Age/Sex: 20-24 Female 2019 2,578
TX_NEW By Age/Sex: 20-24 Male 2019 1,839
TX_NEW By Age/Sex: 50+ Female 2019 13
TX_NEW By Age/Sex: 50+ Male 2019 174
TX_NEW By Key populations: People who inject drugs (PWID) 2019 2
TX_NEW FSW 2019 67
TX_NEW MSM 2019 8
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 9,678
TX_NEW People in prisons and other enclosed settings 2019 24
TX_NEW Pregnancy status 2019 880
TX_NEW Sum of Age/Sex disaggregates 2019 5,900
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 58,088
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 1,456
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Targeted 2019 94
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 874
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Targeted 2019 41
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 36,635
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Targeted 2019 1,737
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 15,105
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Targeted 2019 2,146
TX_PVLS_den Denominator: Indication: Routine 2019 52,262
TX_PVLS_den Denominator: Indication: Targeted 2019 5,826
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 418
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 175
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 18,185
TX_RET Numerator by Status: Breastfeeding 2019 432
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 19,490
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 12,930
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 5,905
TX_RET_den Denominator by Status: Breastfeeding 2019 455
TX_RET_den Denominator by Status: Pregnant 2019 1,205
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 58,483
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 2,741
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 2,701
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 36,852
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 16,168
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 4,849
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Smear Only 2019 565
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 5,613
VMMC_CIRC By Age: 0-60 days 2019 1,098
VMMC_CIRC By Age: 10-14 2019 23,395
VMMC_CIRC By Age: 15-19 2019 9,408
VMMC_CIRC By Age: 2 months - 9 years 2019 3
VMMC_CIRC By Age: 20-24 2019 4,015
VMMC_CIRC By Age: 25-29 2019 1,626
VMMC_CIRC By Age: 50+ 2019 39
VMMC_CIRC By circumcision technique: Device-based VMMC 2019 280
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 38,202
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 38,484
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 38,483
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 36,857
Cross Cutting Budget Categories and Known Amounts Total: $9,563,668
Gender: Gender Based Violence (GBV) $830,234
GBV Prevention
Post GBV Care
Monitoring and Evaluation
Capacity building
Adolescent Girls and Young Women (AGYW) $8,583,434
Water $150,000